References
1. Jones JK. Assessing potential risk of drugs: the elusive target. ACP 1992.
2. Ramaswamy R, Maio V, Diamond JJ et al. Potentially inappropriate prescribing in elderly: assessing doctor knowledge, confidence and barriers. J Eval Clin Pract 2011; 17: 1153-9.
3. Thomas RE, Thomas BC. A systematic review of studies of the STOPP/START 2015 and American Geriatric Society Beers 2015 criteria in patients≥ 65 years. Curr  Aging Sci2019; 12: 121-54.
4. Gorzoni ML, Rosa RF. Beers AGS 2019 criteria in very old hospitalized patients. AMB Rev Assoc Med Bras 2020; 66: 918-23.
5. Sharma R, Bansal P, Garg R et al. Prevalence of potentially inappropriate medication and its correlates in elderly hospitalized patients: A cross-sectional study based on Beers criteria. JFCM 2020; 27: 200.
6. Aguiar JP, Costa LH, da Costa FA, Leufkens HG, Martins AP. Identification of potentially inappropriate medications with risk of major adverse cardiac and cerebrovascular events among elderly patients in ambulatory setting and long-term care facilities. Clin Interv Aging 2019; 14: 535.
7. Duncan AK, Vittone J, Fleming KC, Smith HC, editors. Cardiovascular disease in elderly patients.Mayo Clin Proc 1996: Elsevier.
8. Veehof L, Stewart R, Meyboom-de Jong B, Haaijer-Ruskamp F. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999; 55: 533-6.
9. Mangoni AA, Jackson SH. Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6-14.
10. Zhang X, Zhou S, Pan K et al. Potentially inappropriate medications in hospitalized older patients: a cross-sectional study using the Beers 2015 criteria versus the 2012 criteria. Clin Interv Aging 2017; 12:1697.
11. Sheikh-Taha M, Dimassi H. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA.BMC Cardiovasc Disor 2017; 17: 189.
12. Burkhardt H, Bojarsky G, Gretz N, Gladisch R. Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly?Gerontol 2002; 48: 140-6.
13. Corp I. IBM SPSS Statistics for Windows, Version 24.0. Armonk. IBM Corp NY; 2016.
14. Garcia-Ramos S, Garcia-Poza P, Ramos-Diaz F. Evaluation of inappropriate prescribing according to Beers criteria in cardiology and respiratory medicine departments.Revista de Calidad Asistencial: Organo de la Sociedad Espanola de Calidad Asistencial 2011; 27: 169-74.
15. Corleto VD, Festa S, Di Giulio E, Annibale B. Proton pump inhibitor therapy and potential long-term harm.Curr Opin Endocrinol Diabetes Obes 2014; 21: 3-8.
16. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med 2007; 120: 563-7.
17. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997; 157: 545-52.
18. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35: 1025-30.
19. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886-92.
20. 2019 American Geriatrics Society Beers Criteria® Update Expert Panel, Fick DM, Semla TP, Steinman M et al. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults.J Am Geriatr Soc 2019; 67: 674-94.
21. Markota M, Rummans TA, Bostwick JM, Lapid MI, editors. Benzodiazepine use in older adults: dangers, management, and alternative therapies. Mayo Clinic Proceedings ; 2016: Elsevier.
22. Hughes S, Szeki I, Nash MJ, Thachil J. Anticoagulation in chronic kidney disease patients—the practical aspects. Clin kidney J . 2014; 7:442-9.
23. Undela K, Bansal D, D’Cruz S, Sachdev A, Tiwari P. Prevalence and determinants of use of potentially inappropriate medications in elderly inpatients: a prospective study in a tertiary healthcare setting. Geriatr Gerontol Int 2014; 14: 251-8.
24. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.Bmj 2006; 332: 73-8.
25. Oliveira SBVd, Barroso SCC, Bicalho MAC, Reis AMM. Profile of drugs used for self-medication by elderly attended at a referral center. Einstein (São Paulo) 2018; 16.
26. Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SS. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med 2008; 148: 578-86.
27. Halanych JH, Safford MM, Keys WC et al. Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care 2007; 30: 2999-3004.
28. Medicare Cf, Services M. Chronic conditions among Medicare beneficiaries, chartbook, 2012 edition. Baltimore, MD 2012; 11: 15-21.
29. Toh HJ, Lim ZY, Yap P, Tang T. Factors associated with prolonged length of stay in older patients.Singapore Med J 2017; 58: 134.
30. Wang X, Bonventre JV, Parrish AR. The aging kidney: increased susceptibility to nephrotoxicity.  Int J Mol Sci 2014; 15: 15358-76.